Japan Hospice Holdings Résultats passés
Passé contrôle des critères 1/6
Japan Hospice Holdings has been growing earnings at an average annual rate of 32.2%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 22% per year. Japan Hospice Holdings's return on equity is 18.3%, and it has net margins of 5.1%.
Informations clés
32.2%
Taux de croissance des bénéfices
30.5%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 7.9% |
| Taux de croissance des recettes | 22.0% |
| Rendement des fonds propres | 18.3% |
| Marge nette | 5.1% |
| Prochaine mise à jour des résultats | 14 Nov 2024 |
Mises à jour récentes des performances passées
Ventilation des recettes et des dépenses
Comment Japan Hospice Holdings gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 10,903 | 551 | 384 | 0 |
| 31 Mar 24 | 10,351 | 669 | 350 | 0 |
| 31 Dec 23 | 9,871 | 681 | 344 | 0 |
| 30 Sep 23 | 9,482 | 752 | 340 | 0 |
| 30 Jun 23 | 9,034 | 669 | 341 | 0 |
| 31 Mar 23 | 8,520 | 547 | 390 | 0 |
| 31 Dec 22 | 7,894 | 454 | 384 | 0 |
| 30 Sep 22 | 7,251 | 336 | 372 | 0 |
| 30 Jun 22 | 6,708 | 314 | 358 | 0 |
| 31 Mar 22 | 6,267 | 268 | 334 | 0 |
| 31 Dec 21 | 6,019 | 240 | 343 | 0 |
| 30 Sep 21 | 5,729 | 210 | 324 | 0 |
| 30 Jun 21 | 5,450 | 167 | 334 | 0 |
| 31 Mar 21 | 5,183 | 146 | 336 | 0 |
| 31 Dec 20 | 4,916 | 107 | 332 | 0 |
| 30 Sep 20 | 4,729 | 162 | 359 | 0 |
| 30 Jun 20 | 4,532 | 198 | 357 | 0 |
| 31 Mar 20 | 4,351 | 255 | 347 | 0 |
| 31 Dec 19 | 4,193 | 297 | 342 | 0 |
| 30 Sep 19 | 3,948 | 234 | 335 | 0 |
| 31 Dec 18 | 3,015 | 149 | 285 | 0 |
| 31 Dec 17 | 1,895 | -60 | 209 | 0 |
Des revenus de qualité: 7061 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 7061's current net profit margins (5.1%) are lower than last year (7.4%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 7061's earnings have grown significantly by 32.2% per year over the past 5 years.
Accélération de la croissance: 7061's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 7061 had negative earnings growth (-17.6%) over the past year, making it difficult to compare to the Healthcare industry average (9.6%).
Rendement des fonds propres
ROE élevé: 7061's Return on Equity (18.3%) is considered low.